Yi Chen
Stock Analyst at HC Wainwright & Co.
(3.82)
# 682
Out of 5,182 analysts
498
Total ratings
41.93%
Success rate
11.64%
Average return
Main Sectors:
Stocks Rated by Yi Chen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BLTE Belite Bio | Reiterates: Buy | $200 | $161.21 | +24.07% | 26 | Apr 22, 2026 | |
| OCS Oculis Holding AG | Reiterates: Buy | $44 | $26.26 | +67.56% | 19 | Apr 20, 2026 | |
| VVOS Vivos Therapeutics | Maintains: Buy | $7 → $2.5 | $0.90 | +178.41% | 2 | Apr 17, 2026 | |
| OCUL Ocular Therapeutix | Reiterates: Buy | $21 | $9.44 | +122.46% | 31 | Apr 13, 2026 | |
| BNGO Bionano Genomics | Maintains: Buy | $7 → $6 | $1.20 | +400.00% | 4 | Apr 13, 2026 | |
| LPCN Lipocine | Downgrades: Neutral | n/a | $2.38 | - | 7 | Apr 6, 2026 | |
| VNRX VolitionRx | Maintains: Buy | $1.5 → $1 | $0.14 | +604.23% | 5 | Apr 2, 2026 | |
| COCH Envoy Medical | Initiates: Buy | $2.5 | $0.68 | +267.65% | 1 | Mar 31, 2026 | |
| VANI Vivani Medical | Maintains: Buy | $4 → $3.5 | $1.29 | +171.28% | 8 | Mar 31, 2026 | |
| HROW Harrow | Reiterates: Buy | $70 | $38.21 | +83.22% | 9 | Mar 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5.5 | $0.89 | +515.21% | 3 | Mar 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $10 | $4.37 | +128.83% | 12 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $7.77 | +54.44% | 23 | Mar 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $37 | $23.53 | +57.25% | 1 | Mar 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $89 → $95 | $51.04 | +86.13% | 4 | Mar 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $30 | $8.64 | +247.22% | 16 | Mar 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $30 | $13.81 | +117.23% | 24 | Mar 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $20 | $15.74 | +27.11% | 21 | Feb 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $19 | $17.00 | +11.80% | 2 | Jan 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $36 | $18.59 | +93.65% | 7 | Jan 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3 → $1 | $0.15 | +545.58% | 2 | Jan 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $39 → $50 | $23.66 | +111.33% | 9 | Dec 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $32 | $21.48 | +48.98% | 5 | Dec 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $1.5 | $0.93 | +61.29% | 8 | Dec 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $26 → $39 | $38.13 | +2.28% | 3 | Dec 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $1.70 | - | 24 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $4 | $0.67 | +499.88% | 14 | Nov 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $6.86 | -27.06% | 2 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $2 → $2.5 | $0.29 | +768.06% | 23 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.15 | - | 24 | Sep 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $1.61 | +334.78% | 14 | Sep 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $2.97 | +135.69% | 20 | Sep 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $10 | $4.12 | +143.01% | 5 | Sep 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $2.40 | +316.39% | 17 | Sep 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $3.47 | +159.37% | 2 | Sep 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $8 | $4.10 | +95.12% | 20 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $11.11 | +44.01% | 11 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $25 | $20.05 | +24.69% | 12 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3 | $1.24 | +142.91% | 14 | Apr 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $2.35 | +1,176.60% | 20 | Jan 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $500 | $0.98 | +50,977.74% | 5 | May 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $30 → $34 | $3.56 | +855.06% | 7 | Jul 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $58 → $48 | $11.91 | +303.02% | 8 | Apr 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $19 | $115.68 | -83.58% | 2 | Feb 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.62 | - | 2 | Apr 16, 2020 |
Belite Bio
Apr 22, 2026
Reiterates: Buy
Price Target: $200
Current: $161.21
Upside: +24.07%
Oculis Holding AG
Apr 20, 2026
Reiterates: Buy
Price Target: $44
Current: $26.26
Upside: +67.56%
Vivos Therapeutics
Apr 17, 2026
Maintains: Buy
Price Target: $7 → $2.5
Current: $0.90
Upside: +178.41%
Ocular Therapeutix
Apr 13, 2026
Reiterates: Buy
Price Target: $21
Current: $9.44
Upside: +122.46%
Bionano Genomics
Apr 13, 2026
Maintains: Buy
Price Target: $7 → $6
Current: $1.20
Upside: +400.00%
Lipocine
Apr 6, 2026
Downgrades: Neutral
Price Target: n/a
Current: $2.38
Upside: -
VolitionRx
Apr 2, 2026
Maintains: Buy
Price Target: $1.5 → $1
Current: $0.14
Upside: +604.23%
Envoy Medical
Mar 31, 2026
Initiates: Buy
Price Target: $2.5
Current: $0.68
Upside: +267.65%
Vivani Medical
Mar 31, 2026
Maintains: Buy
Price Target: $4 → $3.5
Current: $1.29
Upside: +171.28%
Harrow
Mar 19, 2026
Reiterates: Buy
Price Target: $70
Current: $38.21
Upside: +83.22%
Mar 16, 2026
Reiterates: Buy
Price Target: $5.5
Current: $0.89
Upside: +515.21%
Mar 11, 2026
Maintains: Buy
Price Target: $9 → $10
Current: $4.37
Upside: +128.83%
Mar 10, 2026
Reiterates: Buy
Price Target: $12
Current: $7.77
Upside: +54.44%
Mar 10, 2026
Initiates: Buy
Price Target: $37
Current: $23.53
Upside: +57.25%
Mar 9, 2026
Maintains: Buy
Price Target: $89 → $95
Current: $51.04
Upside: +86.13%
Mar 9, 2026
Maintains: Buy
Price Target: $32 → $30
Current: $8.64
Upside: +247.22%
Mar 5, 2026
Maintains: Buy
Price Target: $23 → $30
Current: $13.81
Upside: +117.23%
Feb 23, 2026
Maintains: Buy
Price Target: $17 → $20
Current: $15.74
Upside: +27.11%
Jan 27, 2026
Maintains: Buy
Price Target: $18 → $19
Current: $17.00
Upside: +11.80%
Jan 26, 2026
Reiterates: Buy
Price Target: $36
Current: $18.59
Upside: +93.65%
Jan 9, 2026
Reiterates: Buy
Price Target: $3 → $1
Current: $0.15
Upside: +545.58%
Dec 30, 2025
Maintains: Buy
Price Target: $39 → $50
Current: $23.66
Upside: +111.33%
Dec 29, 2025
Reiterates: Buy
Price Target: $32
Current: $21.48
Upside: +48.98%
Dec 26, 2025
Maintains: Buy
Price Target: $4 → $1.5
Current: $0.93
Upside: +61.29%
Dec 5, 2025
Maintains: Buy
Price Target: $26 → $39
Current: $38.13
Upside: +2.28%
Nov 24, 2025
Reiterates: Neutral
Price Target: n/a
Current: $1.70
Upside: -
Nov 17, 2025
Maintains: Buy
Price Target: $3 → $4
Current: $0.67
Upside: +499.88%
Nov 3, 2025
Reiterates: Buy
Price Target: $5
Current: $6.86
Upside: -27.06%
Oct 7, 2025
Maintains: Buy
Price Target: $2 → $2.5
Current: $0.29
Upside: +768.06%
Sep 29, 2025
Downgrades: Neutral
Price Target: n/a
Current: $0.15
Upside: -
Sep 23, 2025
Reiterates: Buy
Price Target: $7
Current: $1.61
Upside: +334.78%
Sep 11, 2025
Reiterates: Buy
Price Target: $7
Current: $2.97
Upside: +135.69%
Sep 4, 2025
Maintains: Buy
Price Target: $12 → $10
Current: $4.12
Upside: +143.01%
Sep 2, 2025
Reiterates: Buy
Price Target: $10
Current: $2.40
Upside: +316.39%
Sep 2, 2025
Reiterates: Buy
Price Target: $9
Current: $3.47
Upside: +159.37%
Aug 12, 2025
Maintains: Buy
Price Target: $12 → $8
Current: $4.10
Upside: +95.12%
Jul 16, 2025
Reiterates: Buy
Price Target: $16
Current: $11.11
Upside: +44.01%
May 5, 2025
Reiterates: Neutral
Price Target: $25
Current: $20.05
Upside: +24.69%
Apr 7, 2025
Reiterates: Buy
Price Target: $3
Current: $1.24
Upside: +142.91%
Jan 2, 2025
Reiterates: Buy
Price Target: $30
Current: $2.35
Upside: +1,176.60%
May 17, 2024
Reiterates: Buy
Price Target: $500
Current: $0.98
Upside: +50,977.74%
Jul 8, 2022
Downgrades: Neutral
Price Target: $30 → $34
Current: $3.56
Upside: +855.06%
Apr 22, 2022
Maintains: Neutral
Price Target: $58 → $48
Current: $11.91
Upside: +303.02%
Feb 17, 2021
Maintains: Buy
Price Target: $18 → $19
Current: $115.68
Upside: -83.58%
Apr 16, 2020
Downgrades: Neutral
Price Target: n/a
Current: $0.62
Upside: -